These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 25626302)

  • 1. [Bone disease in multiple myeloma].
    Irisawa H
    Nihon Rinsho; 2015 Jan; 73(1):42-6. PubMed ID: 25626302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the biology and treatment of bone disease in multiple myeloma.
    Raje N; Roodman GD
    Clin Cancer Res; 2011 Mar; 17(6):1278-86. PubMed ID: 21411443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone Disease in Multiple Myeloma.
    Eda H; Santo L; David Roodman G; Raje N
    Cancer Treat Res; 2016; 169():251-270. PubMed ID: 27696267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloma bone disease: pathogenesis, current treatments and future targets.
    Walker RE; Lawson MA; Buckle CH; Snowden JA; Chantry AD
    Br Med Bull; 2014 Sep; 111(1):117-38. PubMed ID: 25190762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis and management of myeloma bone disease.
    Christoulas D; Terpos E; Dimopoulos MA
    Expert Rev Hematol; 2009 Aug; 2(4):385-98. PubMed ID: 21082944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment strategies for bone disease.
    Roodman GD
    Bone Marrow Transplant; 2007 Dec; 40(12):1139-46. PubMed ID: 17680018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New potential targets for treating myeloma bone disease.
    Roodman GD
    Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6270s-6273s. PubMed ID: 17062712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloma bone disease: pathogenesis and treatment.
    O'Donnell EK; Raje NS
    Clin Adv Hematol Oncol; 2017 Apr; 15(4):285-295. PubMed ID: 28591104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New agents in the Treatment of Myeloma Bone Disease.
    Ring ES; Lawson MA; Snowden JA; Jolley I; Chantry AD
    Calcif Tissue Int; 2018 Feb; 102(2):196-209. PubMed ID: 29098361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Evidence-Based Approach to Myeloma Bone Disease.
    Bingham N; Reale A; Spencer A
    Curr Hematol Malig Rep; 2017 Apr; 12(2):109-118. PubMed ID: 28243849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of myeloma bone disease.
    Roodman GD
    Blood Cells Mol Dis; 2004; 32(2):290-2. PubMed ID: 15003820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone markers in multiple myeloma.
    Heider U; Fleissner C; Zavrski I; Kaiser M; Hecht M; Jakob C; Sezer O
    Eur J Cancer; 2006 Jul; 42(11):1544-53. PubMed ID: 16765040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
    Kupisiewicz K
    Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of multiple myeloma-related bone disease].
    Jurczyszyn A; Grosicki S; Czerniuk MR; Morga R; Małecki K; Skotnicki AB
    Przegl Lek; 2013; 70(11):950-7. PubMed ID: 24697037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bone disease in multiple myeloma and its mechanism].
    Abe M
    Clin Calcium; 2006 Apr; 16(4):565- 71. PubMed ID: 16582506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-host cell interactions in the bone disease of myeloma.
    Fowler JA; Edwards CM; Croucher PI
    Bone; 2011 Jan; 48(1):121-8. PubMed ID: 20615487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloma bone disease: Progress in pathogenesis.
    Xi H; An R; Li L; Wang G; Tao Y; Gao L
    Prog Biophys Mol Biol; 2016 Nov; 122(2):149-155. PubMed ID: 27496181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dickkopf-1: a suitable target for the management of myeloma bone disease.
    Gavriatopoulou M; Dimopoulos MA; Christoulas D; Migkou M; Iakovaki M; Gkotzamanidou M; Terpos E
    Expert Opin Ther Targets; 2009 Jul; 13(7):839-48. PubMed ID: 19530987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloma bone disease.
    Sezer O
    Hematology; 2005; 10 Suppl 1():19-24. PubMed ID: 16188625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the microenvironment in multiple myeloma bone disease.
    Huston A; Roodman GD
    Future Oncol; 2006 Jun; 2(3):371-8. PubMed ID: 16787117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.